Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

INDUSTRY 4NIH 2OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Myeloid 2

Conditions

Myelodysplastic Syndromes 114Leukemia, Myeloid, Acute 103Leukemia 83Precursor Cell Lymphoblastic Leukemia-Lymphoma 79Myeloproliferative Disorders 65Leukemia, Myelogenous, Chronic, BCR-ABL Positive 61Leukemia, Myelomonocytic, Chronic 60Lymphoma, Non-Hodgkin 56Leukemia, Lymphocytic, Chronic, B-Cell 53Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 41Blast Crisis 41Leukemia, Myeloid, Chronic-Phase 40Multiple Myeloma 39Hodgkin Disease 37Lymphoma 35Leukemia, Myeloid, Accelerated Phase 35Congenital Abnormalities 35Anemia, Refractory, with Excess of Blasts 35Primary Myelofibrosis 33Lymphoma, Follicular 33Lymphoma, Large B-Cell, Diffuse 32Burkitt Lymphoma 30Lymphoma, Mantle-Cell 29Myelodysplastic-Myeloproliferative Diseases 27Lymphoma, Large-Cell, Immunoblastic 27Lymphoma, B-Cell, Marginal Zone 27Polycythemia Vera 24Thrombocythemia, Essential 23Neuroblastoma 23Neoplasms, Plasma Cell 23

Interventions

Sodium Chloride 1BNT162 Vaccine 12019-nCoV Vaccine mRNA-1273 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Hypersensitivity × Myeloid × Clear all
NCT04761822 2025-08-12

SARS

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 2 Completed
746 enrolled 28 charts
Myeloid

COVID-19, Hypersensitivity, Mastocytosis, Severe Acute Respiratory Syndrome

NCT00557895 2019-11-25

Evaluation and Long-Term Follow-Up of Patients With Allergic and Inflammatory Disorders

National Institutes of Health Clinical Center (CC)

Terminated
288 enrolled
Myeloid

Eosinophilic enteropathy, Asthma, Dermatitis, Atopic, Food Hypersensitivity, Hypersensitivity, Mastocytosis, Peanut Hypersensitivity, Eosinophilic Esophagitis, Rhinitis, Allergic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡